Cargando…
Identification and Analysis of An Epigenetically Regulated Five-lncRNA Signature Associated With Outcome and Chemotherapy Response in Ovarian Cancer
The deregulation of long non-coding RNAs (lncRNAs) by epigenetic alterations has been implicated in cancer initiation and progression. However, the epigenetically regulated lncRNAs and their association with clinical outcome and therapeutic response in ovarian cancer (OV) remain poorly investigated....
Autores principales: | Yang, Hao, Gao, Lin, Zhang, Meiling, Ning, Ning, Wang, Yan, Wu, Di, Li, Xiaomei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7940383/ https://www.ncbi.nlm.nih.gov/pubmed/33708773 http://dx.doi.org/10.3389/fcell.2021.644940 |
Ejemplares similares
-
Characterization of BRCA1/2-Directed ceRNA Network Identifies a Novel Three-lncRNA Signature to Predict Prognosis and Chemo-Response in Ovarian Cancer Patients With Wild-Type BRCA1/2
por: Zhang, Meiling, et al.
Publicado: (2020) -
Identification and Validation of an EMT-Related LncRNA Signature for HNSCC to Predict Survival and Immune Landscapes
por: Feng, Chunyu, et al.
Publicado: (2022) -
Identification of the Prognostic Significance of Somatic Mutation-Derived LncRNA Signatures of Genomic Instability in Lung Adenocarcinoma
por: Geng, Wei, et al.
Publicado: (2021) -
Identification of a TLR-Induced Four-lncRNA Signature as a Novel Prognostic Biomarker in Esophageal Carcinoma
por: Liu, Jing, et al.
Publicado: (2020) -
Identification of an Immune-Related LncRNA Signature in Gastric Cancer to Predict Survival and Response to Immune Checkpoint Inhibitors
por: Ding, Zuoyou, et al.
Publicado: (2021)